| A whole-genome association study of major determinants for host control of HIV-1 J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ... science 317 (5840), 944-947, 2007 | 1503 | 2007 |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... The Lancet Rheumatology 2 (8), e474-e484, 2020 | 1044 | 2020 |
| Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ... Aids 14 (5), 499-507, 2000 | 766 | 2000 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 473 | 2009 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 472 | 2011 |
| Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy O Kirk, C Pedersen, A Cozzi-Lepri, F Antunes, V Miller, JM Gatell, ... Blood, The Journal of the American Society of Hematology 98 (12), 3406-3412, 2001 | 351 | 2001 |
| Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre A Mocroft, M Youle, A Moore, CA Sabin, S Madge, AC Lepri, M Tyrer, ... Aids 15 (2), 185-194, 2001 | 330 | 2001 |
| Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and … RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ... The Lancet infectious diseases 9 (7), 409-417, 2009 | 318 | 2009 |
| Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects A De Luca, R Bugarini, AC Lepri, M Puoti, E Girardi, A Antinori, A Poggio, ... Archives of internal medicine 162 (18), 2125-2132, 2002 | 317 | 2002 |
| CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ... The lancet HIV 2 (3), e98-e106, 2015 | 315 | 2015 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 287 | 2005 |
| Risk factor for central venous catheter-related infections in surgical and intensive care units ML Moro, EF Vigano, AC Lepri, ... Infection Control & Hospital Epidemiology 15 (4), 253-264, 1994 | 264 | 1994 |
| Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection N Sidenius, CFM Sier, H Ullum, BK Pedersen, AC Lepri, F Blasi, ... Blood, The Journal of the American Society of Hematology 96 (13), 4091-4095, 2000 | 251 | 2000 |
| Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count G Marchetti, A Cozzi-Lepri, E Merlini, GM Bellistrì, A Castagna, M Galli, ... Aids 25 (11), 1385-1394, 2011 | 241 | 2011 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 221 | 2015 |
| Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS M Dorrucci, P Pezzotti, AN Phillips, AC Lepri, G Rezza, ... Journal of Infectious Diseases 172 (6), 1503-1508, 1995 | 221 | 1995 |
| Relationship between HAART adherence and adipose tissue alterations A Ammassari, A Antinori, A Cozzi-Lepri, MP Trotta, G Nasti, AL Ridolfo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S140-S144, 2002 | 203 | 2002 |
| Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy B Grund, JV Baker, SG Deeks, J Wolfson, D Wentworth, A Cozzi-Lepri, ... PloS one 11 (5), e0155100, 2016 | 202 | 2016 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 196 | 2014 |
| Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus K Saira, X Lin, JV DePasse, R Halpin, A Twaddle, T Stockwell, B Angus, ... Journal of virology 87 (14), 8064-8074, 2013 | 177 | 2013 |
